Clinicopathologic characteristics and survival of male breast cancer

International Journal of Clinical Oncology

Volumn 19, Issue 2, 2014, Pages 280-287

  Liu, Dongying ^a   Xie, Guangru ^a   Chen, Ming ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN NANKAI HOSPITAL   (China)

Author keywords

HER 2; Male breast cancer; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; PROGESTERONE; PROLACTIN; ERBB2 PROTEIN, HUMAN; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; MORBIDITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ADULT; AGED; BREAST TUMOR; CANCER STAGING; CHEMISTRY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84899927392     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0555-4     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Anonymous (2008) Cancer incidence in five continents, vol IX. IARC Sci Publ, pp 1-837
3. Nirmul D, Pegoraro RJ, Jialal I et al (1983) The sex hormone profile of male patients with breast cancer. Br J Cancer 48:423-427 (Pubitemid 13000813)
4. Ballerini P, Recchione C, Cavalleri A et al (1990) Hormones in male breast cancer. Tumori 76:26-28 (Pubitemid 20133416)
5. Ravandi-Kashani F, Hayes TG (1998) Male breast cancer: a review of the literature. Eur J Cancer 34:1341-1347 (Pubitemid 28370923)
6. Thorlacius S, Tryggvadottir L, Olafsdottir GH et al (1995) Linkage to BRCA2 region in hereditary male breast cancer. Lancet 346:544-545
7. Andre S, Pinto AE, Laranjeira C et al (2007) Male and female breast cancer - differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis. Pathobiology 74:323-327 (Pubitemid 350273703)
8. Anderson WF, Jatoi I, Tse J et al (2010) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 28:232-239
9. Onami S, Ozaki M, Mortimer JE et al (2010) Male breast cancer: an update in diagnosis, treatment and molecular profiling. Maturitas 65:308-314
10. Kiluk JV, Lee MC, Park CK et al (2011) Male breast cancer: management and follow-up recommendations. Breast J 17:503-509
11. Ottini L, Palli D, Rizzo S et al (2010) Male breast cancer. Crit Rev Oncol Hematol 73:141-155
12. Tawil AN, Boulos FI, Chakhachiro ZI et al (2012) Clinicopathologic and immunohistochemical characteristics of male breast cancer: a single center experience. Breast J 18:65-68
13. La Vecchia C, Levi F, Lucchini F (1992) Descriptive epidemiology of male breast cancer in Europe. Int J Cancer 51:62-66
14. Anonymous (2004) Male breast cancer rates rising. Health News 10:13
15. Ndom P, Um G, Bell EM et al (2012) A meta-analysis of male breast cancer in Africa. Breast 21(3):237-241
16. Tajima N, Tsukuma H, Oshima A (2001) Descriptive epidemiology of male breast cancer in Osaka, Japan. J Epidemiol 11:1-7 (Pubitemid 33798346)
17. Zhou FF, Xia LP, Guo GF et al (2010) Changes in therapeutic strategies in Chinese male patients with breast cancer: 40 years of experience in a single institute. Breast 19:450-455
18. Liu T, Tong Z, He L et al (2011) Clinicopathological characteristics and survival analysis of 87 male breast cancer cases. Breast Care (Basel) 6:446-451
19. Bourhafour M, Belbaraka R, Souadka A et al (2011) Male breast cancer: a report of 127 cases at a Moroccan institution. BMC Res Notes 4:219
20. Giordano SH, Cohen DS, Buzdar AU et al (2004) Breast carcinoma in men: a population-based study. Cancer 101:51-57 (Pubitemid 38812422)
21. Rudlowski C, Friedrichs N, Faridi A et al (2004) Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat 84:215-223 (Pubitemid 38445371)
22. Arslan UY, Oksuzoglu B, Ozdemir N et al (2012) Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol 29:554-560
23. Foerster R, Foerster FG, Wulff V et al (2011) Matched-pair analysis of patients with female and male breast cancer: a comparative analysis. BMC Cancer 11:335
24. Dakin HK, Gray S, Barnes PJ et al (2007) Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray. Breast Cancer Res Treat 105:169-175 (Pubitemid 47366886)
25. Borgen PI, Wong GY, Vlamis V et al (1992) Current management of male breast cancer. A review of 104 cases. Ann Surg 215:451-457
26. Anderson WF, Althuis MD, Brinton LA et al (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83:77-86 (Pubitemid 38141895)
27. Giordano SH (2005) A review of the diagnosis and management of male breast cancer. Oncologist 10:471-479
28. Hill TD, Khamis HJ, Tyczynski JE et al (2005) Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol 15:773-780 (Pubitemid 41550245)
29. Pich A, Margaria E, Chiusa L et al (1999) Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Br J Cancer 79:959-964 (Pubitemid 29082133)
30. Fogh S, Hirsch AE, Langmead JP et al (2011) Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer 11:39-45
31. Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-792 (Pubitemid 32222155)
32. Salvadori B, Saccozzi R, Manzari A et al (1994) Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A:930-935 (Pubitemid 24256237)
33. Joshi MG, Lee AK, Loda M et al (1996) Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77:490-498 (Pubitemid 26047570)
34. Erlichman C, Murphy KC, Elhakim T (1984) Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 2:903-909 (Pubitemid 14037768)
35. Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135:734-748
36. Misra SP, Misra V, Dwivedi M (1996) Cancer of the breast in a male cirrhotic: is there an association between the two? Am J Gastroenterol 91:380-382 (Pubitemid 26067354)
37. Calabresi E, De Giuli G, Becciolini A et al (1976) Plasma estrogens and androgens in male breast cancer. J Steroid Biochem 7:605-609